 | This redirect does not require a rating on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
How widely is it used edit
Sounds like it was experimental in 2006. Do any national health services use it as normal practice ? Rod57 (talk) 18:00, 15 December 2009 (UTC)
"normal" levels edit
In general, a rise in CA 15-3 levels may indicate a larger aggregate tumor biomass. Marked increase may be seen if the breast cancer spreads (metastasizes) to other organs, such as into the bones or the liver.
A person without breast cancer will generally have a level of CA 15-3 of 30 or lower. However a result in this range does not definitively rule out cancer. 25% to 30% of breast cancers do not raise CA 15-3 levels.
combination of CA 15-3 and CEA diagnostic specificity was 97%excellent for detection and exclusion of recurrence in the follow-up of breast cancer patients if decision-making is based on individual reference limits." PMID 7652495 edit
- "The diagnostic specificity was 97%. ... The combination of CA 15-3 and CEA is an excellent for detection and exclusion of recurrence in the follow-up of breast cancer patients if decision-making is based on individual reference limits."
Hölzel WG, Beer R, Deschner W, Griesmacher A, Müller MM.
Individual reference ranges of CA 15-3, MCA and CEA in recurrence of breast cancer.
Scand J Clin Lab Invest Suppl. 1995; 221:93-101. — Preceding unsigned comment added by Ocdncntx (talk • contribs) 20:19, 5 October 2011 (UTC)
Duplicate page edit
There are two CA15-3 pages. Both appear to be stubs, but clearly one should be pointed at the other.drh (talk) 18:30, 20 January 2013 (UTC)